Posts tagged as:

boehringer

Tweet- From LexisNexis® Mealey’s™ Daily Legal News. BALTIMORE – Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to the federal government to resolve civil allegations that it marketed three drugs for off-label uses, promoted high doses of two drugs and paid kickbacks to health care professionals, according to a settlement agreement filed Oct. 25 in […]

{ 0 comments }